World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
51
Citations
6937
World Ranking
4376
National Ranking
1691

Martin L. Moore publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Martin L. Moore sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 136 publications — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Martin L. Moore D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Martin L. Moore sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 51 D-Index — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Martin L. Moore is affiliated with Emory University in the United States. Their research primarily focuses on medicine, with significant contributions in the fields of epidemiology and infectious diseases, as well as subfields such as ecology, pulmonary and respiratory medicine, and surgery.

The scientist's research covers multiple topics, including:

  • Respiratory viral infections research
  • Viral gastroenteritis research and epidemiology
  • SARS-CoV-2 and COVID-19 research
  • Pneumonia and respiratory infections
  • Virology and viral diseases
  • Bacteriophages and microbial interactions
  • Neonatal respiratory health research

Recent publications by Martin L. Moore include:

  • "Assembly of respiratory syncytial virus matrix protein lattice and its coordination with fusion glycoprotein trimers," 2024, Nature Communications
  • "Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2," 2022, npj Vaccines
  • "An RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c Mice," 2022, The Journal of Infectious Diseases
  • "A Respiratory Syncytial Virus Attachment Gene Variant Associated with More Severe Disease in Infants Decreases Fusion Protein Expression, Which May Facilitate Immune Evasion," 2020, Journal of Virology
  • "One mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2," 2021, bioRxiv (Cold Spring Harbor Laboratory)

Martin L. Moore has co-authored multiple papers with several frequent collaborators. Notable co-authors include Christopher C. Stobart, Christina A. Rostad, Melissa H. Bloodworth, R. Stokes Peebles, and Anne L. Hotard.

The scientist's work is published in a variety of venues, with multiple papers appearing in:

  • UNC Libraries
  • npj Vaccines
  • Nature Communications
  • Journal of Virology
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma

    Nandini Krishnamoorthy;Anupriya Khare;Timothy B Oriss;Mahesh Raundhal

  • Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses.

    Jeong-Joong Yoon;Mart Toots;Sujin Lee;Myung-Eun Lee

  • Differential Pathogenesis of Respiratory Syncytial Virus Clinical Isolates in BALB/c Mice

    Kate L. Stokes;Michael H. Chi;Kaori Sakamoto;Dawn C. Newcomb

  • Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus.

    Nicholas W. Lukacs;Martin L. Moore;Brian D. Rudd;Aaron A. Berlin

  • Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma.

    Amy S. Feldman;Yuan He;Martin L. Moore;Martin L. Moore;Marc B. Hershenson

  • A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis

    Anne L. Hotard;Fyza Y. Shaikh;Sujin Lee;Dan Yan

  • Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin

    Matthew T. Stier;Melissa H. Bloodworth;Shinji Toki;Dawn C. Newcomb

  • A Chimeric A2 Strain of Respiratory Syncytial Virus (RSV) with the Fusion Protein of RSV Strain Line 19 Exhibits Enhanced Viral Load, Mucus, and Airway Dysfunction

    Martin L. Moore;Michael H. Chi;Cindy Luongo;Nicholas W. Lukacs

  • CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells

    Tatiana Chirkova;Songbai Lin;Antonius G. P. Oomens;Kelsey A. Gaston

  • A Functional IL-13 Receptor is Expressed on Polarized Murine CD4+ Th17 Cells and IL-13 Signaling Attenuates Th17 Cytokine Production

    Dawn C. Newcomb;Weisong Zhou;Martin L. Moore;Kasia Goleniewska

  • Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice

    Fu-Shi Quan;Yonghwan Kim;Sujin Lee;Hong Yi

  • RNA virus reverse genetics and vaccine design.

    Christopher C. Stobart;Martin L. Moore

  • A Critical Phenylalanine Residue in the Respiratory Syncytial Virus Fusion Protein Cytoplasmic Tail Mediates Assembly of Internal Viral Proteins into Viral Filaments and Particles

    Fyza Y. Shaikh;Reagan G. Cox;Aaron W. Lifland;Anne L. Hotard

  • Interference Between Respiratory Syncytial Virus and Human Rhinovirus Infection in Infancy.

    Niek B. Achten;Pingsheng Wu;Louis Bont;Maarten O. Blanken

  • The Respiratory Syncytial Virus Fusion Protein and Neutrophils Mediate the Airway Mucin Response to Pathogenic Respiratory Syncytial Virus Infection

    Kate L. Stokes;Michael G. Currier;Kaori Sakamoto;Sujin Lee

  • Impact of Pollution, Climate, and Sociodemographic Factors on Spatiotemporal Dynamics of Seasonal Respiratory Viruses

    Chantel Sloan;Martin L. Moore;M.P.H. Tina Hartert M.D.

  • Cross-resistance mechanism of respiratory syncytial virus against structurally diverse entry inhibitors

    Dan Yan;Sujin Lee;Vidhi D. Thakkar;Ming Luo

  • Differences in the Nasopharyngeal Microbiome During Acute Respiratory Tract Infection With Human Rhinovirus and Respiratory Syncytial Virus in Infancy.

    Christian Rosas-Salazar;Meghan H. Shilts;Andrey Tovchigrechko;Seth Schobel

  • A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation.

    Christopher C. Stobart;Christina A. Rostad;Zunlong Ke;Rebecca S. Dillard

  • Respiratory Syncytial Virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G gene

    Seth A. Schobel;Seth A. Schobel;Karla M. Stucker;Martin L. Moore;Larry J. Anderson

  • An overview of respiratory syncytial virus.

    Jia Meng;Christopher C. Stobart;Anne L. Hotard;Martin L. Moore

Frequent Co-Authors

R. Stokes Peebles
R. Stokes Peebles Vanderbilt University
Tina V. Hartert
Tina V. Hartert Vanderbilt University Medical Center
Dawn C. Newcomb
Dawn C. Newcomb Vanderbilt University Medical Center
Richard K. Plemper
Richard K. Plemper Georgia State University
Sang-Moo Kang
Sang-Moo Kang Georgia State University
James E. Crowe
James E. Crowe Vanderbilt University Medical Center
Barney S. Graham
Barney S. Graham Morehouse School of Medicine
James D. Chappell
James D. Chappell Vanderbilt University Medical Center
Nicholas W. Lukacs
Nicholas W. Lukacs University of Michigan–Ann Arbor
Kelli L. Boyd
Kelli L. Boyd Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career options, including roles in healthcare, research, and data management. For students interested in clinical practice and patient-centered care, becoming a functional medicine nurse practitioner is a promising path. This role combines medical knowledge with holistic approaches to improve patient outcomes.

On the administrative side, healthcare coding and information management are growing fields that intersect with microbiological research and clinical documentation. Careers like Certified Professional Coders are vital to the healthcare industry, and exploring the certified professional coder salary can provide insight into the financial benefits of this pathway.

Advancing your education with a master in health information management salary can lead to leadership roles managing healthcare data systems, which are essential for microbiology-related research and public health initiatives.

For those seeking flexible study options, pursuing a cahiim accredited health information management degree online offers the opportunity to gain industry-recognized credentials while balancing work or personal commitments.

Best Scientists Citing Martin L. Moore

Trending Scientists

Recently Published Articles